tiprankstipranks
Marvel Biosciences Corp (TSE:MRVL)
:MRVL
Canadian Market
MRVL
Marvel Biosciences Corp
RESEARCH TOOLSreports

Marvel Biosciences Corp (MRVL) Stock News & Sentiment

43 Followers
Marvel Biosciences Lowers Conversion Price on Proposed Debenture Financing
Premium
Company Announcements
Marvel Biosciences Lowers Conversion Price on Proposed Debenture Financing
9h ago
Marvel Biosciences to Raise Up to $500,000 via Convertible Debenture Offering
Premium
Company Announcements
Marvel Biosciences to Raise Up to $500,000 via Convertible Debenture Offering
5d ago
Marvel Biosciences Wins Non-Dilutive Backing for MB-204 Phase I Trial
Premium
Company Announcements
Marvel Biosciences Wins Non-Dilutive Backing for MB-204 Phase I Trial
7d ago
Marvel Biosciences Wins Alberta Funding to Advance MB-204 Into Phase I Trials
Premium
Company Announcements
Marvel Biosciences Wins Alberta Funding to Advance MB-204 Into Phase I Trials
15d ago
Marvel Biosciences Taps Novotech to Run Phase I Trial of Lead Neurodrug MB-204
Premium
Company Announcements
Marvel Biosciences Taps Novotech to Run Phase I Trial of Lead Neurodrug MB-204
20d ago
Marvel Biosciences Wins Key U.S. Patent for Lead Neurology Drug MB-204
Premium
Company Announcements
Marvel Biosciences Wins Key U.S. Patent for Lead Neurology Drug MB-204
27d ago
Marvel Biosciences Backs European Purine Meeting to Bolster A2A Neurology Strategy
Premium
Company Announcements
Marvel Biosciences Backs European Purine Meeting to Bolster A2A Neurology Strategy
1M ago
More TSE:MRVL News >

MRVL News on the Web

Marvel Biosciences Lowers Conversion Price on Proposed Debenture Financing
TipRanks News
Neutral
Marvel Biosciences to Raise Up to $500,000 via Convertible Debenture Offering
TipRanks News
Neutral
Marvel Biosciences Wins Non-Dilutive Backing for MB-204 Phase I Trial
TipRanks News
Neutral
Marvel Biosciences Wins Alberta Funding to Advance MB-204 Into Phase I Trials
TipRanks News
Neutral
Marvel Biosciences Taps Novotech to Run Phase I Trial of Lead Neurodrug MB-204
TipRanks News
Neutral
Marvel Biosciences Wins Key U.S. Patent for Lead Neurology Drug MB-204
TipRanks News
Bearish
Marvel Biosciences Backs European Purine Meeting to Bolster A2A Neurology Strategy
TipRanks News
Neutral
Marvel Biosciences Secures Chinese Patent for Lead Drug Candidate MB-204
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
TSE:MRVL
Sector Average
Media Buzz
This Week2 articles
Weekly Average1.5 articles
News Sentiment
This Week50%
Sector Average63%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TSE:MRVL’s Media Buzz Sentiment?
2 articles about TSE:MRVL were published this week. In an average week, 1.5 articles are published.
    What is TSE:MRVL’s weekly average amount of articles?
    In an average week, 1.5 articles about TSE:MRVL are published.
      What is TSE:MRVL’s News Sentiment?
      50% of articles about TSE:MRVL were positive this week, compared to its sector average of 63%.
        Technology Stocks that are Trending in the News
        MRTMarti Technologies
        RCTRedCloud Holdings plc
        6814Furuno Electric Co., Ltd.
        BBBlackBerry
        6521OXIDE Corp.
        Showing the stocks with the most bullish news sentiment over the past week